Ventilatory efficiency is superior to peak oxygen uptake for prediction of lung resection cardiovascular complications.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 23 02 2022
accepted: 29 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

Ventilatory efficiency (VE/VCO2 slope) has been shown superior to peak oxygen consumption (VO2) for prediction of post-operative pulmonary complications in patients undergoing thoracotomy. VE/VCO2 slope is determined by ventilatory drive and ventilation/perfusion mismatch whereas VO2 is related to cardiac output and arteriovenous oxygen difference. We hypothesized pre-operative VO2 predicts post-operative cardiovascular complications in patients undergoing lung resection. Lung resection candidates from a published study were evaluated by post-hoc analysis. All of the patients underwent preoperative cardiopulmonary exercise testing. Post-operative cardiovascular complications were assessed during the first 30 post-operative days or hospital stay. One-way analysis of variance or the Kruskal-Wallis test, and multivariate logistic regression were used for statistical analysis and data summarized as median (IQR). Of 353 subjects, 30 (9%) developed pulmonary complications only (excluded from further analysis), while 78 subjects (22%) developed cardiovascular complications and were divided into two groups for analysis: cardiovascular only (n = 49) and cardiovascular with pulmonary complications (n = 29). Compared to patients without complications (n = 245), peak VO2 was significantly lower in the cardiovascular with pulmonary complications group [19.9 ml/kg/min (16.5-25) vs. 16.3 ml/kg/min (15-20.3); P<0.01] but not in the cardiovascular only complications group [19.9 ml/kg/min (16.5-25) vs 19.0 ml/kg/min (16-23.1); P = 0.18]. In contrast, VE/VCO2 slope was significantly higher in both cardiovascular only [29 (25-33) vs. 31 (27-37); P = 0.05] and cardiovascular with pulmonary complication groups [29 (25-33) vs. 37 (34-42); P<0.01)]. Logistic regression analysis showed VE/VCO2 slope [OR = 1.06; 95%CI (1.01-1.11); P = 0.01; AUC = 0.74], but not peak VO2 to be independently associated with post-operative cardiovascular complications. VE/VCO2 slope is superior to peak VO2 for prediction of post-operative cardiovascular complications in lung resection candidates.

Identifiants

pubmed: 35960723
doi: 10.1371/journal.pone.0272984
pii: PONE-D-22-05505
pmc: PMC9374210
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0272984

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur J Cardiothorac Surg. 2016 Apr;49(4):1054-8; discussion 1058
pubmed: 26604295
Circ Heart Fail. 2020 May;13(5):e006729
pubmed: 32362167
Lung Cancer. 2018 Nov;125:218-222
pubmed: 30429023
Ann Thorac Surg. 2012 Jun;93(6):1802-6
pubmed: 22560968
Eur Respir J. 2009 Jul;34(1):17-41
pubmed: 19567600
Anaesthesia. 2018 Jan;73 Suppl 1:34-42
pubmed: 29313903
Eur J Cardiothorac Surg. 2016 Oct;50(4):772-779
pubmed: 27059429
Eur J Cardiothorac Surg. 2010 Jul;38(1):14-9
pubmed: 20356758
J Neurosurg Anesthesiol. 2014 Oct;26(4):273-85
pubmed: 24978064
Anesth Analg. 1999 Aug;89(2):514-9
pubmed: 10439777
Ann Thorac Surg. 2014 Apr;97(4):1135-40
pubmed: 24565405
Chest Surg Clin N Am. 1999 Aug;9(3):527-41, vii-viii
pubmed: 10459428
Ann Thorac Surg. 2003 Apr;75(4):1340-8
pubmed: 12683600
Circulation. 2000 Jun 20;101(24):2803-9
pubmed: 10859285
J Appl Physiol (1985). 2006 Nov;101(5):1474-80
pubmed: 16873603
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):140-4
pubmed: 18391638
J Card Fail. 2010 Oct;16(10):835-42
pubmed: 20932466
J Am Coll Cardiol. 1997 Jun;29(7):1585-90
pubmed: 9180123
J Thorac Dis. 2013 Jun;5(3):217-22
pubmed: 23825750
Circulation. 2012 Feb 14;125(6):773-81
pubmed: 22219349
Eur J Cardiothorac Surg. 2020 May 1;57(5):874-880
pubmed: 31845993
JACC Heart Fail. 2013 Oct;1(5):427-32
pubmed: 24621975
Chest. 2013 May;143(5 Suppl):e166S-e190S
pubmed: 23649437
Anesthesiology. 2020 Sep;133(3):510-522
pubmed: 32487822
Europace. 2010 Oct;12(10):1360-420
pubmed: 20876603
Ann Thorac Surg. 2022 Jan 21;:
pubmed: 35074321
Ann Thorac Surg. 2016 Nov;102(5):1725-1730
pubmed: 27496629
J Am Coll Surg. 2016 Jun;222(6):992-1000.e1
pubmed: 27118714
Ther Clin Risk Manag. 2019 Oct 04;15:1173-1182
pubmed: 31632044
Circ Heart Fail. 2012 Sep 1;5(5):579-85
pubmed: 22773109
Am Heart J. 2004 Feb;147(2):354-60
pubmed: 14760336

Auteurs

Andrej Mazur (A)

Department of Anesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic.
Faculty of Medicine, Masaryk University, Brno, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.

Kristian Brat (K)

Faculty of Medicine, Masaryk University, Brno, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
Department of Respiratory Diseases, University Hospital Brno, Czech Republic.

Pavel Homolka (P)

Faculty of Medicine, Masaryk University, Brno, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
Department of Sports Medicine and Rehabilitation, St. Anne's University Hospital, Brno.

Zdenek Merta (Z)

Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Department of Respiratory Diseases, University Hospital Brno, Czech Republic.

Michal Svoboda (M)

Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.

Monika Bratova (M)

Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Department of Respiratory Diseases, University Hospital Brno, Czech Republic.

Vladimir Sramek (V)

Department of Anesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic.
Faculty of Medicine, Masaryk University, Brno, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.

Lyle J Olson (LJ)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States of America.

Ivan Cundrle (I)

Department of Anesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic.
Faculty of Medicine, Masaryk University, Brno, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH